Beyond hepatology, MASH is a systemic condition involving liver-related issues (such as fibrosis, cirrhosis, liver failure, hepatocellular carcinoma, and liver transplantation), metabolic complications (like type 2 diabetes), and extrahepatic consequences (including cardiovascular disease, chronic kidney disease, and extrahepatic cancers) [38]
Insugen-R 100IU/ml Refil 3 ml contains Human Insulin
Additionally, semaglutide has been shown to promote weight loss, improve blood pressure, and reduce inflammation markers, all of which contribute to its cardioprotective effects
It also improved other health indicators, like physical functioning and systolic blood pressure, in the subsequent 48 weeks compared with switching to a placebo
It is important to recognize that sexual dysfunction is common in individuals with obesity and type 2 diabetesthe very populations for whom semaglutide is prescribed
Please see full study designs by clicking the link above